Wednesday, May 04, 2011 1:04:58 PM
May 4, 2011 (Marketwire) --
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 05/04/11 -- i-minerals inc. (TSX VENTURE:IMA)(PINK SHEETS:IMAHF) ("the Company") announces it has entered into a purchase agreement to acquire an undivided 100% interest in two State of Idaho mineral leases in Latah County Idaho. The two leases cover a total area of 320 acres and are contiguous with other mineral leases held by the Company. Consideration payable is US$10,000 and the issuance of 50,000 shares. The transaction is subject to regulatory approval including that of the TSX Venture Exchange (the "Exchange") and securities issued will be subject to the policies of the Exchange.
A. Lamar Long, CPG, is a qualified person ("QP") for i-minerals inc. and has reviewed and approved the contents of this release.
About i-minerals inc.
i-minerals holds ten minerals leases in northwestern Idaho that hosts Kelly's Basin feldspar-quartz deposit that is the subject of an ongoing feasibility study. A pre-feasibility study completed by SRK Consulting (USA) Inc. of Denver Co ("SRK"), calculated a NPV of $61 million and an IRR of 19%. Preliminary exploration work on occurrences of primary clay deposits has identified variable concentrations of kaolinite, halloysite, quartz and feldspar. The Company commissioned SRK to complete and initial assessment of the primary clay deposits through a Preliminary Economic Assessment (the "PEA") which is based upon limited, widely spaced drilling over large areas. While additional assessment work is required to fully assess the economic viability of the deposits, the PEA yielded a NPV of $95 million and an IRR of 48% and indicated these primary clay deposits may represent the largest deposit of halloysite in North America. Halloysite is a unique tubular shaped alumina-silicate mineral often referred to as a halloysite nanotube which is being increasingly used in nanotechnology applications.
i-minerals inc.
Thomas M. Conway, President & CEO
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM